Showing posts with label oncogene-induced. Show all posts
Showing posts with label oncogene-induced. Show all posts

Oncogene Induced Cellular Senescence Elicits an Anti-Warburg Effect

  1. Mingxi Li1,2,†
  2. Kenneth R. Durbin2,†,
  3. Steve M. M. Sweet2
  4. Jeremiah D. Tipton3,
  5. Yupeng Zheng2,
  6. Neil L. Kelleher2,3,

ABSTRACT


Cellular senescence, an irreversible cell cycle arrest induced by a diversity of stimuli, has been considered as an innate tumor suppressing mechanism with implications and applications in cancer therapy. Using a targeted proteomics approach we show that fibroblasts induced into senescence by expression of oncogenic Ras exhibit a decrease of global acetylation on all core histones, consistent with formation of senescence-associated heterochromatic foci. We also detected clear increases in repressive markers (e.g., >50% elevation of H3K27me2/3) along with decreases in histone marks associated with increased transcriptional expression/elongation (e.g., H3K36me2/3). Despite the increases in repressive marks of chromatin, 179 loci (of 2206 total) were found to be upregulated by global quantitative proteomics. The changes in the cytosolic proteome indicated an upregulation of mitochondrial proteins and downregulation of proteins involved in glycolysis. These alterations in primary metabolism are opposite of the well-known Warburg effect observed in cancer cells. This study significantly improves our understanding of stress-induced senescence and provides a potential application for triggering it in anti-proliferative strategies that target the primary metabolism in cancer cells.

A complex secretory program orchestrated by the inflammasome controls paracrine senescence

  • Juan Carlos Acosta,
  • Ana Banito,
  • Torsten Wuestefeld,
  • Athena Georgilis,
  • Peggy Janich,
  • Jennifer P. Morton,
  • Dimitris Athineos,
  • Tae-Won Kang,
  • Felix Lasitschka,
  • Mindaugas Andrulis,
  • Gloria Pascual,
  • Kelly J. Morris,
  • Sadaf Khan,
  • Hong Jin,
  • Gopuraja Dharmalingam,
  • Ambrosius P. Snijders,
  • Thomas Carroll,
  • David Capper,
  • Catrin Pritchard,
  • Gareth J. Inman,
  • Thomas Longerich,
  • Owen J. Sansom,
  • Salvador Aznar Benitah,
  • Lars Zender
  • Jesús Gil

Abstract

Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15INK4b and p21CIP1. Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.

The main focus of ageing research is to prevent/combat age-related disease and disability, allowing everyone to live healthier lives for longer.